VanEck Pharmaceutical ETF PPH
121.71 USD +0.13 (+0.11%)
At closeNov 12, 2026, 4:00 AM EST
121.66 -0.05 -0.04%
Pre-market · Nov 12, 4:00 AM ET
120.07 Day range 121.83
97.52 52-week range 123.53
- YTD
- +17.97%
- 1 year
- +23.94%
- Market cap
- 1.10B
- EPS (ttm)
- 4.29
- P/E ratio
- 28.40
- YTD return
- +17.97%
- 1-year return
- +23.94%
- Volume
- 236.02K
- Avg volume
- 323.87K
- Open
- 120.50
- Previous close
- 121.58
- Day's range
- 120.07 – 121.83
- 52-week range
- 97.52 – 123.53
5D -0.76 (-0.62%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 113.25
- 200-day average
- 108.41
About VanEck Pharmaceutical ETF
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
News
Your note
Sign in to keep a note on PPH — it syncs with the Stock Master app.